716 related articles for article (PubMed ID: 16386326)
21. Some drugs more equal than others: pseudo-generics and commercial practice.
Probyn AJ
Aust Health Rev; 2004 Nov; 28(2):207-17. PubMed ID: 15527401
[TBL] [Abstract][Full Text] [Related]
22. [Prescription of generic drugs in general practice. Results of a survey of general practitioners].
Simmenroth-Nayda A; Hummers-Pradier E; Ledig T; Jansen R; Niebling W; Bjerre LM; Kochen MM; Himmel W
Med Klin (Munich); 2006 Sep; 101(9):705-10. PubMed ID: 16977394
[TBL] [Abstract][Full Text] [Related]
23. [Early achievements of the Danish pharmaceutical industry-7].
Grevsen JV; Kirkegaard H; Kruse E; Kruse PR
Theriaca; 2014; (42):31-62. PubMed ID: 25816561
[TBL] [Abstract][Full Text] [Related]
24. The generics in transplantation and the rules on their use.
Masri M
Exp Clin Transplant; 2003 Jun; 1(1):65-8. PubMed ID: 15859910
[TBL] [Abstract][Full Text] [Related]
25. Exploring knowledge and perceptions on generic drugs of final year pharmacy school students in Greece.
Souliotis K; Golna C; Kani C; Markantonis S
Expert Rev Pharmacoecon Outcomes Res; 2019 Oct; 19(5):569-574. PubMed ID: 30658041
[No Abstract] [Full Text] [Related]
26. [Medical problems and risks of switching drugs according to legal requirements of drug discount contracts in Germany].
Pruszydlo MG; Quinzler R; Kaltschmidt J; Haefeli WE
Dtsch Med Wochenschr; 2008 Jul; 133(27):1423-8. PubMed ID: 18592450
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical promotion and GP prescription behaviour.
Windmeijer F; de Laat E; Douven R; Mot E
Health Econ; 2006 Jan; 15(1):5-18. PubMed ID: 15945041
[TBL] [Abstract][Full Text] [Related]
28. Generic medications for you, but brand-name medications for me.
Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
[TBL] [Abstract][Full Text] [Related]
29. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
Mansfield SJ
Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceutical pricing and reimbursement reforms in Greece.
Yfantopoulos J
Eur J Health Econ; 2008 Feb; 9(1):87-97. PubMed ID: 17619920
[TBL] [Abstract][Full Text] [Related]
31. Physicians' opinions and experiences of the Pharmaceutical Benefits Reform.
Andersson K; Jörgensen T; Carlsten A
Scand J Public Health; 2006; 34(6):654-9. PubMed ID: 17132599
[TBL] [Abstract][Full Text] [Related]
32. Strategic options for brand-name prescription drugs when patents expire.
Mehta SC; Mehta SS
Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309
[TBL] [Abstract][Full Text] [Related]
33. Innovation strategies for generic drug companies: moving into supergenerics.
Ross MS
IDrugs; 2010 Apr; 13(4):243-7. PubMed ID: 20373253
[TBL] [Abstract][Full Text] [Related]
34. Current approaches to the use of generic antiepileptic drugs.
Krämer G; Biraben A; Carreno M; Guekht A; de Haan GJ; Jedrzejczak J; Josephs D; van Rijckevorsel K; Zaccara G
Epilepsy Behav; 2007 Aug; 11(1):46-52. PubMed ID: 17537678
[TBL] [Abstract][Full Text] [Related]
35. [Generics: authorization to market and quality guarantees].
De Muylder JA
Rev Med Brux; 2000 Sep; 21(4):A276-8. PubMed ID: 11068480
[TBL] [Abstract][Full Text] [Related]
36. Opinions of pharmacy, medicine, and pharmaceutical industry leaders about hypothetical therapeutic-interchange legislation.
Segal R; Grines LL; Pathak DS
Am J Hosp Pharm; 1988 Mar; 45(3):570-7. PubMed ID: 3369459
[TBL] [Abstract][Full Text] [Related]
37. Economic aspects of the new Spanish laws on pharmaceutical preparations.
Antoñanzas F; Oliva J; Pinillos M; Juàrez C
Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
[TBL] [Abstract][Full Text] [Related]
38. [A proposal for the prevention of ethical problems related to drug promotion: a national network for drug information].
Civaner M
Turk Psikiyatri Derg; 2008; 19(3):310-7. PubMed ID: 18791884
[TBL] [Abstract][Full Text] [Related]
39. Demand-side policies to encourage the use of generic medicines: an overview.
Dylst P; Vulto A; Simoens S
Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
[TBL] [Abstract][Full Text] [Related]
40. Does brand differentiate pharmaceuticals?
Bednarik J
Neuro Endocrinol Lett; 2005 Dec; 26(6):635-52. PubMed ID: 16380705
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
